P4 Outcome Following Switch Between Brand Name And Generic Tacrolimus In Paediatric Population

January 2018 in “ Archives of Disease in Childhood ”

Peter Foxon, Swetha Vijayan

TLDR Switching to generic tacrolimus was safe, effective, and saved money.

The study evaluated the clinical outcomes of switching 36 paediatric patients from the brand name tacrolimus (Prograf) to its generic counterpart (Adoport) at Nottingham Children’s Renal Unit. The switch was monitored by reviewing Tacrolimus levels and clinical variations in immunosuppression before and after the switch. Results showed that most patients tolerated the switch well, with stable Tacrolimus levels and no significant changes in creatinine levels. Only one patient experienced hair loss and requested to revert to Prograf, and one patient required a dose adjustment. The switch resulted in cost savings for NHS England, supporting the use of Adoport as a cost-effective alternative to Prograf.

View this study on doi.org →

Discuss this study in the Community →

Similar Research

5 / 913 results

research Graft-Versus-Host Disease: Comprehensive Overview by the American Academy of Dermatology

58 citations, April 2012 in “Journal of the American Academy of Dermatology”

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

research Medications

January 2016 in “Springer eBooks”

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

research Principles of Therapy of Skin Diseases

January 2012

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

research Ruxolitinib Protects Skin Stem Cells And Maintains Skin Homeostasis In Murine Graft-Versus-Host Disease

33 citations, January 2018 in “Blood”

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

research Acne Keloidalis Nuchae in Renal Transplant Patients Receiving Tacrolimus and Sirolimus

6 citations, April 2016 in “Australasian journal of dermatology”

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

P4 Outcome Following Switch Between Brand Name And Generic Tacrolimus In Paediatric Population

Related Community Posts Join

community Help! Minoxidil or Duta to avoid Shed of long hair.

community Scalp Sunburns cause permanent hair loss. UPF hats protect you. Watch if you use Tretinoin on the scalp

community Scalp Sunburns can cause permanent hair loss. UPF hats protect you.

community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

community RT1640 - Gray Hair Reversal Recipe